Skip to content
Back to Guavy Wire
Stocks

Amgen Sees Significant Institutional Investment Amid Quarter Results

Instruments
AMGN
Share

Ausdal Financial Partners Inc., an institutional investor, acquired a new stake in Amgen Inc. (NASDAQ:AMGN) during the second quarter of this year.

The company reported acquiring 2,893 shares of the medical research company's stock, valued at approximately $1,048,000, according to its recent filing with the Securities & Exchange Commission.

This is not an isolated instance of institutional investment in Amgen. Other investors have also bought and sold shares of the company.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc